Jack Boan Student Essay Competition | Justice Emmett M. Hall Foundation

/0 Comments/in , /by
The annual Jack Boan Student Essay competition, sponsored by the Justice Emmett M. Hall Foundation, offers prizes for winning essays on important topics in Canadian healthcare services and policy – for undergraduates, masters and doctoral students. The deadline to submit is March 1, 2022. Winners will be recognized at the (more…)

5th Patient Group Pathway Model to Accessing Cancer Clinical Trials and Real-World Evidence Conference

/0 Comments/in , /by
The 2021, 5th Cancer Clinical Trials and RWE  Conference Registration is Open!  The Registration link is:   https://tinyurl.com/CTCONF2021 Over the course of the past several years, Colorectal Cancer Canada (CCC) has endeavoured and made significant progress in fostering patient and patient group partnerships among stakeholders who have been advocating for their engagement (more…)

Ontario Health – Person-Centred Virtual Cancer Care Clinical Guidance document

/0 Comments/in , /by
The Person-Centred Virtual Cancer Care Clinical Guidance document is now available. The COVID-19 pandemic has significantly increased the use of virtual care in many areas, such as cancer care. During the first 7 months of the pandemic, virtual cancer care visits (including telephone or video appointments) increased from ~1-2% to (more…)

CAHSPR – Call for Nominations for 2022 Hall Laureate

/0 Comments/in , /by
The Board of Directors of the Justice Emmett Hall Memorial Foundation is seeking nominations for the 2022 Hall Laureate. The Emmett Hall Memorial Lectureship commemorates the father of Canadian Medicare with an annual address at the CAHSPR Conference. Sponsored by the Hall Foundation, the Hall Laureate is awarded each year (more…)

IAEA soliciting applications from National Cancer Control Planning Experts

/0 Comments/in , , /by
Closing Date:  October 18 2021 The International Atomic Energy Agency’s Programme of Action for Cancer Therapy (PACT), in collaboration with the World Health Organization (WHO), is soliciting applications from qualified National Cancer Control Planning Experts. More detailed information can be found through the link here. Main Purpose: In order to (more…)

CCS Awards for Excellence in Cancer Research

/0 Comments/in , /by
Since 1993, the Canadian Cancer Society has recognized individuals who have made, and are making, valuable contributions to the cancer research ecosystem in Canada through their Awards for Excellence in Cancer Research. CCS is pleased to launch the 2021 Awards for Excellence in Cancer Research nomination process. To see the 2020 (more…)

PMPRB Stakeholder Consultation

/0 Comments/in /by
The Patented Medicine Prices Review Board (PMPRB) invites stakeholders to comment on three proposed amendments to the new PMPRB Guidelines related to the decision to delay the coming-into-force date of the Regulations Amending the Patented Medicines Regulations (“Regulations”) a further six months, from July 1, 2021 to January 1, 2022.  (more…)

2021 Canadian Cancer Research Conference – Abstract deadline July 5

/0 Comments/in , /by
The Canadian Cancer Research Conference provides an excellent opportunity to present research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Trainees (undergraduate students, graduate students, and postdoctoral fellows) and new principal investigators are encouraged to present their work.  Call for Abstracts Abstract submissions for (more…)

2021 CADTH Symposium – Call for Abstracts

/0 Comments/in , /by
CADTH is now accepting abstracts for workshops, panels, debates, breakfast sessions, oral presentations, and posters for the 2021 CADTH Symposium to be held online on November 2, 3, and 4. This year’s theme is Uncertain Times, Imperfect Evidence, and the Imperative to Act. Learn more about the theme. Abstracts must (more…)

PMPRB Report: Alignment Among Public Formularies in Canada, Part 2: Oncology Medicines

/0 Comments/in /by
Visit https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/formularies-part2-oncology-medicines.html to read the full report from Canada’s Patented Medicine Pricing Review Board (PMPRB). The current report, Part 2 in the Alignment of Public Formularies in Canada series, addresses the public coverage of oncology medicines reviewed by the Canadian Agency for Drugs and Technologies in Health’s (CADTH) interim Joint Oncology Drug Review (more…)